EDX Medical Group has partnered with Caris Life Sciences to introduce the Caris MI Clarity test in the UK. The AI-powered diagnostic test assesses both early and long-term breast cancer recurrence risk, providing risk predictions covering up to 15 years for eligible postmenopausal patients...